tiprankstipranks
Trending News
More News >
Argent Biopharma Ltd (RGTLF)
:RGTLF
US Market

Argent Biopharma (RGTLF) Income Statement

Compare
31 Followers

Argent Biopharma Income Statement

Last quarter (Q4 2022), Argent Biopharma's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Argent Biopharma's net income was $―. See Argent Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 203.70K$ 1.45M$ 1.81M$ 1.31M$ 174.66K
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 1.29M$ 751.94K$ 247.69K$ 491.41K$ 481.13K
EBITDA
$ -15.77M$ -11.05M$ -20.90M$ -14.58M$ -18.15M
Operating Income
$ -18.67M$ -16.88M$ -14.43M$ -12.07M$ -11.80M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -17.53M$ -11.76M$ -20.83M$ -15.87M$ -19.36M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Argent Biopharma Earnings and Revenue History